Program Overview:
A clinical expert in cHL will provide new insights into refractory or relapsed
classical Hodgkin lymphoma (cHL). This slide-based presentation will:
- Provide an overview of cHL and review the role of the immune system in cHL
- Review clinical and safety data for refractory or relapsed cHL
- Discuss clinical considerations for appropriate patients with refractory
or relapsed cHL
Duration – 60 minutes
Register Here!